Good points:
- BTT trial over 80% complete and due for completion in January. (was supposed to finish end of year but that is good enough)
Bad points:
- no cap on bonuses or salaries, especially for director.
- cessation of R&D (this should not have been compromised)
- no strategic partnership agreements reached yet
Overall I'm bullish on VCR and can't believe the price is at this level. Especially when compared to Thoratec capitalisation.
What I would really like is for VCR to obtain a strategic partnership agreement and continue full steam ahead with R&D. I would definitely partake in SPP then.
- Forums
- ASX - By Stock
- VCR
- funding plan
VCR
ventracor limited
funding plan
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VCR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online